Summary
Several lines of evidence suggest an involvement of adenosine A2a receptor (A2aAR) mediated adenosinergic neuromodulation in the etiopathogenesis of schizophrenia. We therefore perfomed a systematic mutation scan of the complete coding region of the human A2aAR gene in a sample of 42 schizophrenic patients. We detected one rare naturally occurring receptor variant (Gly-340-Ser) and two silent mutations (405C/T and 1083C/T). To our knowledge the Gly-340-Ser substitution is the first naturally occurring molecular variant of the A2aAR identified. Determining the frequency of the three variants in 42 unrelated healthy controls, we observed a significant trend towards an overrepresentation of the 1083T variant in patients when compared to controls (p=0.041). This trend was followed up in a large independent replication sample. However, we were not able to confirm the original trend in the second sample (p=0.367). The Ser-340 variant was found in a single schizophrenic individual. Investigation of the patient's family revealed independent segregation between the Ser-340 variant and psychiatric illness. Our data suggest that genetically determined structural variation of the A2aAR does not play a major role in the development of schizophrenia.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3rd edn, revised (DSM-III-R). American Psychiatric Association Press, Washington DC
Bridges AJ, Moos HW, Szotek DL, Trivedi BK, Bristol JA, Heffner TG, Bruns RF, Downs DA (1987) N6-(2,2-diphenylethyl)-adenosine, a novel adenosine receptor agonist with antipsychotic-like activity. J Med Chem 30: 1709–1711
Budowle B, Chakraborty R, Giusti AM, Eisenberg AJ, Allen RC (1991) Analysis of the VNTR locus D1S80 by the PCR followed by high resolution PAGE. Am J Hum Genet 48: 137–144
Coon H, Holik J, Hoff M, Reimherr F, Wender P, Myles-Worsley M, Waldo M, Freedman R, Byerley W (1994) Analysis of chromosome 22 markers in nine schizophrenia pedigrees. Am J Med Genet 54: 72–79
Deckert J, Nöthen MM, Bryant SP, Schuffenhauer S, Schofield PR, Spurr NK, Propping P (1996) Mapping of the human adenosine A2a receptor gene: relation to potential schizophrenia loci on chromosome 22q and exclusion from the CATCH 22 deleted region. Hum Genet (in press)
Endicott J, Spitzer RL (1978) A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 35: 837–844
Ferre S, O'Connor WT, Sbaprud P, Ungerstedt U, Fuxe K (1994) Antagonistic interaction between adenosine A2a and dopamine D2 receptors in the ventral striopallidal system. Implications for the treatment of schizophrenia. Neuroscience 63: 765–773
Fink JS, Weaver DR, Rivkees SA, Peterfreund RA, Pollack AE, Adler EM, Reppert SM (1992) Molecular cloning of the rat A2 adenosine receptor: selective coexpression with D2 dopamine receptors in rat striatum. Mol Brain Res 14: 186–195
Furlong T, Pierce K, Selbie L, Shine J (1992) Molecular characterization of a human brain adenosine A2 receptor. Mol Brain Res 15: 62–66
Karayiorgou M, Morris MA, Morrow B, Shprintzen RJ, Goldberg R, Borrow J, Gos A, Nestadt G, Wolyniec PS, Lasseter VK, Eisen H, Childs B, Kazazian HH, Kucherlapati R, Antonarakis SE, Pulver AE, Housman DE (1995) Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc Natl Acad USA 92: 7612–7616
Le F, Townsend-Nicholson A, Baker E, Sutherland GR, Schofield PF (1996) Characterization and chromosomal localization of the human A2a adenosine receptor subtype gene: ADORA2A. Biochem Biophys Res Commun 223: 461–467
Libert F, Parmentier M, Lefort A, Dinsart C, Van Sande J, Maenhaut C, Simons MJ, Dumont JE, Vassart G (1989) Selective amplification and cloning of four new members of the G-protein coupled receptor family. Science 244: 569–572
Lucas PB, Pickar D, Kelsoe J, Rapaport M, Pato C, Hommer D (1990) Effects of the acute administration of caffeine in patients with schizophrenia. Biol Psychiatry 28: 35–40
Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 16: 1215
Orita M, Suzuki Y, Sekiya T, Hayashi K (1989) Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5: 874–879
Palmer TM, Stiles GL (1995) Adenosine receptors. Neuropharmacol 34: 683–694
Peterfreund RA, MacCollin M, Gusella J, Fink JS (1996) Characterization and expression of the human A2a adenosine receptor gene. J Neurochem 66: 362–368
Propping P, Nöthen MM (1995) Schizophrenia: genetic tools for unraveling the nature of a complex disorder. Proc Natl Acad Sci USA 92: 7607–7608
Pulver AE, Karayiorgou M, Wolyniec PS, Lasseter VK, Kasch L, Nestadt G, Antonarakis S, Housman D, Kazazian HH, Meyers D, Ott J, Lamacz M, Liang K-Y, Hanfelt J, Ullrich G, DeMarchi N, Ramu E, McHugh PR, Adler L, Thomas M, Carpenter WT, Manschreck T, Gordon CT, Kimberland M, Babb R, Puck J, Childs B (1994) Sequential strategy to identify a susceptibility gene on chromosome 22q12-q13.1, part 1. Am J Med Genet 54: 36–43
Sanger F, Nicklen S, Coulsen AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74: 137–142
Schwab SG, Lerer B, Albus M, Maier W, Hallmayer J, Fimmers R, Lichtermann D, Minges J, Bondy B, Ackenheil M, Altmark D, Hasib D, Gur E, Ebstein RP, Wildenauer DB (1995) Potential linkage for schizophrenia on chromosome 22q12-13: a replication study. Am J Med Genet 60: 436–443
Vallada HP, Gill M, Sham P, Lim LCC, Nanko S, Asherson P, Murray RM, McGuffin P, Owen M, Collier D (1995) Linkage studies on chromosome 22 in familial schizophrenia. Am J Med Genet 60: 139–146
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Deckert, J., Nöthen, M.M., Rietschel, M. et al. Human adenosine A2a receptor (A2aAR) gene: systematic mutation screening in patients with schizophrenia. J. Neural Transmission 103, 1447–1455 (1996). https://doi.org/10.1007/BF01271259
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01271259